课题基金 / 基金详情

Absorbable and Low-Cost Radioseeds for Malignant Tumors

Absorbable and Low-Cost Radioseeds for Malignant Tumors
用于恶性肿瘤的可吸收且低成本的放射种子
批准号:
7486650
负责人:
YONGREN Benjamin PENG
金额:
$36.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-11 至 2009-08-31

项目摘要

项目成果

YONGREN Benjamin PENG的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本I期研究的目的是证明创造用于治疗前列腺肿瘤的定时生物吸收Pd-103种子的可行性。定时生物吸收种子具有钛种子、高剂量率临时种子、外束辐射和其他治疗选择的综合好处。此外,定时生物吸收种子可能提供理想的治疗后选择,植入物的总生物吸收和最低的总体治疗成本。这项拟议的快速通道I期研究的具体目标是:(1)确定具有适当内在生物吸收率并适合生物吸收谱工程控制的可吸收基质;(2)确定最佳成像种子尺寸;(3)控制生物吸收,使种子累积泄漏的Pd-103放射性物质不超过1%,并在2年内估计种子基质的完全生物吸收;(4)确定并推荐最佳的基质化学和生物吸收工程条件,以深入研究快速通道II期的Pd-103泄漏和生物吸收剖面;(5)利用ISO方法证明了所选定时生物吸收种子的体外生物相容性。实现I期设定的关键和可衡量的里程碑将确保拟议的快速通道II期的成功完成,从而为前列腺肿瘤和其他恶性肿瘤的治疗提供高影响生物吸收种子。
英文摘要
DESCRIPTION (provided by applicant): The objective of this Phase I research is to demonstrate the feasibility of creating timed-bioabsorbable Pd-103 seeds for the treatment of prostate tumors. Timed- bioabsorbable seeds have the combined benefits of titanium seeds, high dose rate temporary seeds, external beam radiation and other treatment options. In addition, timed-bioabsorbable seeds potentially offer desirable post-treatment options, total bioabsorption of the implants and the lowest overall treatment cost. The specific aims of this proposed Fast Track Phase I research are to (1) identify absorbable matrices that have appropriate intrinsic bioabsorption rates and are suitable for engineered control of bioabsorption profiles; (2) determine seed dimension for optimal imaging; (3) control the bioabsorption such that the cumulative Pd-103 radioactivity leakage from seeds is 1% or less and the complete bioabsorption of seed matrices is estimated within 2 years; (4) determine and recommend optimal matrix chemistry and bioabsorption engineering conditions for in-depth studies of Pd-103 leakages and bioabsorption profiles in the Fast-Track Phase II; and (5) demonstrate the biocompatibility for selected timed-bioabsorbable seeds in vitro using ISO methods. Achieving key and measurable milestones set in Phase I will ensure successful completion of the proposed Fast Track Phase II, leading to high impact bioabsorbable seeds for the treatment of prostate tumors and other malignant tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Radioactive Stents for Brachytherapy of Esophageal Cancers
  • 批准号:
    8834929
  • 项目类别:
  • 资助金额:
    $80.23万
  • 财政年份:
    2015
  • 负责人:
    YONGREN Benjamin PENG
  • 依托单位:
Radioactive Stents for Brachytherapy of Esophageal Cancers
  • 批准号:
    9063476
  • 项目类别:
  • 资助金额:
    $74.88万
  • 财政年份:
    2015
  • 负责人:
    YONGREN Benjamin PENG
  • 依托单位:
Radioactive Stents for Brachytherapy of Esophageal Cancers
  • 批准号:
    8524567
  • 项目类别:
  • 资助金额:
    $20.26万
  • 财政年份:
    2013
  • 负责人:
    YONGREN Benjamin PENG
  • 依托单位:
Molecularly Engineered Biomaterials for Minimally Invasive Dental Treatment
  • 批准号:
    8593065
  • 项目类别:
  • 资助金额:
    $18.21万
  • 财政年份:
    2013
  • 负责人:
    YONGREN Benjamin PENG
  • 依托单位:
海外基金